Edoxaban versus Warfarin in Patients with Atrial Fibrillation
2013 · New England Journal of Medicine · 5,063 citations
https://doi.org/10.1056/nejmoa1310907
J
Jeffrey I. Weitz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
773
Papers
74.0K
Citations
118
h-index
480
i10-index
Jeffrey I. Weitz is an academic researcher from McMaster University Medical Centre. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Atrial Fibrillation Management and Outcomes & Blood Coagulation and Thrombosis Mechanisms. The author has an h-index of 118, co-authored 658 publications.
ORCID: 0000-0002-1092-7550Papers by this author
worksComparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 · The Lancet · 4,878 citations
https://doi.org/10.1016/s0140-6736(13)62343-0
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 · New England Journal of Medicine · 2,231 citations
https://doi.org/10.1056/nejmoa1302507
Apixaban for Extended Treatment of Venous Thromboembolism
2012 · New England Journal of Medicine · 1,317 citations
https://doi.org/10.1056/nejmoa1207541
Parenteral Anticoagulants
2012 · CHEST Journal · 1,051 citations
https://doi.org/10.1378/chest.11-2291
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
2017 · New England Journal of Medicine · 752 citations
https://doi.org/10.1056/nejmoa1700518
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat